Cargando…
Treatment with natalizumab during the Covid-19 pandemic in multiple sclerosis patients
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498380/ http://dx.doi.org/10.1016/j.jns.2021.118107 |
| _version_ | 1784580144837427200 |
|---|---|
| author | Díaz-Díaz, Judit Ramirez, Clara Isabel Ortiz-Pica, Marta García-Yusta, Elena Gómez-Estevez, Irene Oreja-Guevara, Celia |
| author_facet | Díaz-Díaz, Judit Ramirez, Clara Isabel Ortiz-Pica, Marta García-Yusta, Elena Gómez-Estevez, Irene Oreja-Guevara, Celia |
| author_sort | Díaz-Díaz, Judit |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8498380 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84983802021-10-08 Treatment with natalizumab during the Covid-19 pandemic in multiple sclerosis patients Díaz-Díaz, Judit Ramirez, Clara Isabel Ortiz-Pica, Marta García-Yusta, Elena Gómez-Estevez, Irene Oreja-Guevara, Celia J Neurol Sci Article Elsevier 2021-10 2021-10-08 /pmc/articles/PMC8498380/ http://dx.doi.org/10.1016/j.jns.2021.118107 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Díaz-Díaz, Judit Ramirez, Clara Isabel Ortiz-Pica, Marta García-Yusta, Elena Gómez-Estevez, Irene Oreja-Guevara, Celia Treatment with natalizumab during the Covid-19 pandemic in multiple sclerosis patients |
| title | Treatment with natalizumab during the Covid-19 pandemic in multiple sclerosis patients |
| title_full | Treatment with natalizumab during the Covid-19 pandemic in multiple sclerosis patients |
| title_fullStr | Treatment with natalizumab during the Covid-19 pandemic in multiple sclerosis patients |
| title_full_unstemmed | Treatment with natalizumab during the Covid-19 pandemic in multiple sclerosis patients |
| title_short | Treatment with natalizumab during the Covid-19 pandemic in multiple sclerosis patients |
| title_sort | treatment with natalizumab during the covid-19 pandemic in multiple sclerosis patients |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498380/ http://dx.doi.org/10.1016/j.jns.2021.118107 |
| work_keys_str_mv | AT diazdiazjudit treatmentwithnatalizumabduringthecovid19pandemicinmultiplesclerosispatients AT ramirezclaraisabel treatmentwithnatalizumabduringthecovid19pandemicinmultiplesclerosispatients AT ortizpicamarta treatmentwithnatalizumabduringthecovid19pandemicinmultiplesclerosispatients AT garciayustaelena treatmentwithnatalizumabduringthecovid19pandemicinmultiplesclerosispatients AT gomezestevezirene treatmentwithnatalizumabduringthecovid19pandemicinmultiplesclerosispatients AT orejaguevaracelia treatmentwithnatalizumabduringthecovid19pandemicinmultiplesclerosispatients |